Pinterest Twitter By Federico Martinez – May 17, 2021 WhatsApp WhatsApp Facebook Previous articleCarry the Load West Coast Relay to stop in OdessaNext articleBoard to consider salary increases Federico Martinez Medical Center Hospital Pfizer COVID-19 vaccinations for youths 12 to 15 years old are now available at a handful of locations in Odessa, including Medical Center Hospital Urgent Care Clinics at JBS Parkway and on University Boulevard, MCH President and CEO Russell Tippin said.MCH began offering the vaccinations last week after the Texas Expert Vaccine Panel approved the measure.“We stocked up on the vaccine in anticipation of the approval and began providing the vaccine last week,” Tippin said. “The vaccinations are available on a walk-in basis, but youths must be accompanied by a parent or guardian.”There is no cost to get the Pfizer vaccine at MCH urgent care centers, Tippin said.According to the Texas Department of State Health Services website tinyurl.com/ephh6n7d, other Odessa locations that have reported having the Pfizer vaccine available include CVS Pharmacy, 3050 W. University Blvd., Odessa Regional Medical Center, the Ector County Health Department, Market Street Pharmacy and United Pharmacy. DSHS recommends contacting hospitals, clinics and pharmacies in advance to make sure they still have the Pfizer vaccine in stock and whether an appointment is required.The CDC reported that there were no COVID-related deaths reported in the State of Texas on Sunday, said Tippin, who called the news “a major accomplishment for Texas.” Facebook Local News Twitter Youth COVID vaccines available in Odessa Pinterest
Enzo Biochem, Inc. (NYSE:ENZ) announced today a co-marketing partnership between its Enzo Life Sciences subsidiary of Farmingdale, New York, a world leader in non-radioactive probe technology, and BioTek Instruments of Winooski, Vermont, a privately held global leader in the development, manufacture and sale of microplate instrumentation for drug discovery and life science applications, involving powerful, integrated solutions for high throughput live cell analysis.Aimed at research institutions, as well as biotechnology and pharmaceutical companies, this reagents-instrumentation collaboration creates a highly reproducible and reliable platform for live cell analysis, offering a cost effective alternative to dedicated microplate imaging-based systems, which often are too costly for investigators to implement.The collaboration will be formally launched next month at MipTec 2009 in Basel, Switzerland with the presentation of the scientific poster, entitled “A cost-effective workflow for high-throughput screening of G-Protein-Coupled Receptors (GPCRs).” The poster details the use of Enzo’s new FluoForte™ Calcium Assay Kit for monitoring intracellular calcium mobilization with BioTek’s Synergy™ Mx Monochromator-based Multi-Mode Microplate Reader.Drugs targeting GPCRs represent the core of modern medicine, accounting for the majority of the best-selling drugs and roughly 40% of all prescription pharmaceuticals on the market today. Using BioTek’s Precision™ XS Automated Sample Processor for all dispensing steps in conjunction with Enzo’s proprietary calcium indicator dye technology and Synergy Mx Microplate Reader provides a small-scale, cost effective, automated cell-based screening approach for identifying GPCR agonists and antagonists. The described assay workflow provides low sample-to-sample variability and excellent assay performance in a miniaturized format.“Through this collaboration, researchers will be able to obtain integrated instrumentation and reagent solutions that are high-performance, yet affordable,“ said Wayne Patton, PhD, Chief Scientific Officer for Enzo Life Sciences. “The collaboration will provide validated turn-key solutions to the research community.”“Previously, a major source of frustration for many researchers has been that selected assays were not compatible with a particular instrument and vice-versa,” said Peter Banks, PhD, Scientific Director for BioTek Instruments. “Our companies each provide key expertise and capabilities in the live-cell analysis arena bringing together BioTek’s capabilities in microplate and dispensing technology that matches perfectly with Enzo’s cutting-edge live cell analysis reagents and kits.”About EnzoEnzo Biochem is engaged in the research, development, manufacture and licensing of innovative health care products and technologies based on molecular biology and genetic engineering techniques, and in providing diagnostic services to the medical community. Enzo’s Life Sciences division develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research among others. Its catalog of over 30,000 products serves the molecular biology, drug discovery and pathology research markets. The Company’s therapeutic division is in various stages of clinical evaluation of its proprietary immune regulation medicines for uveitis and Crohn’s disease and conducts pre-clinical research on several candidate compounds aimed at producing new mineral and organic bone, including technology that could provide therapy for osteoporosis and fractures, among other applications. Enzo’s Clinical Labs division provides routine and esoteric reference laboratory services for physicians in the New York Metropolitan and New Jersey areas. Underpinning the Company’s technology and operations is an extensive intellectual property estate in which Enzo owns or licenses over 240 patents worldwide, and has pending applications for over 200 more. For more information visit our website www.enzo.com(link is external).About BioTek InstrumentsBioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. The company has distribution in over 70 countries and an installed base of 75,000 instruments. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.Safe Harbor StatementExcept for historical information, the matters discussed in this news release may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this press release.Source: BioTek. Enzo. Farmingdale, NY, and Winooski, VT, October 2, 2009 —
That they didn’t break somewhere along the line represents a significant change for the Clippers, whose league-wide reputation coming into this season was they crumbled when alternate paths to victory needed to be forged.Or to be more blunt, the Clippers were easily intimidated.“In the past, people came in here trying to push us around,” Clippers forward Matt Barnes said. “And mentally I think it worked.”That’s happening less and less under Rivers and with a more mature Blake Griffin elevating his game physically and mentally.There is an undeniable resiliency to these Clippers, who continue to defy injuries and multiple roster additions to continue their ascent in the Western Conference.Their win against the Warriors was their ninth in a row and strengthened their hold on the third seed in the Western Conference — and with it, home-court advantage in the first round of the playoffs.And they are playing without J.J. Redick and Jamal Crawford, two key role players.Yet they continue to win.Better yet, they continue to find ways to win.Like Wednesday, when they overcame the slow shooting nights of Chris Paul and Darren Collison and others to beat the Warriors.“I’m proud,” Griffin said. “Proud of the way we fought. Proud of the way guys handled themselves. Guys were fighting. I’m just proud of the way we played.”In years past, that probably didn’t happen.Not long ago, the knock on the Clippers was they were front runners, just a high-flying, high-wire act that was fun to watch when things were going well.But the minute someone turned up the heat and took them out of their comfort zone with some hard fouls or aggressive defense, the trouble started. They’d get angry or down on themselves. The body language changed, their flow slowed to a crawl. The defense and communication waned and the silly fouls and mental errors mounted.At that point, the Clippers would crumble.This year, that no longer seems to be the case.The Warriors were a prime example.“It was one of those games you just had to keep fighting and finally it kind of broke our way,” Rivers said. “To me, that’s growth. I don’t know if we win this game earlier in the year. It’s one of those games where some teams let go of the rope. But I thought we hung in there, and I’m proud of them.”There is a reason for that, according to Barnes.“Now that we’re mentally locked in, I think it’s harder to (get in our head),” he said,” “You’re going to have to beat us playing basketball, and that’s hard to do.”As one of the Clippers’ noted agitators, even Barnes openly questioned their toughness last year. It all came to a head in the first round of the playoffs against Memphis when he blasted the Clippers for getting punked by the Grizzlies.The Clippers lost that series, and over the summer sweeping changes were made — not the least of which was getting rid of Vinny Del Negro as coach in favor of Rivers, the hard-driving force behind the Boston Celtics’ championship run in 2009.Rivers didn’t just bring instant credibility to a locker room starving for proven leadership. He brought a no-nonsense, no-excuse philosophy in which misfortune is quickly dealt with and overcome — not the justification for failure.The Clippers are acquiring a similar taste for adversity, having won in a variety of fashions with an ever-changing lineup.“We’ve had so many injuries, so many ups and downs, and we’re still getting guys acclimated,” Barnes said. “But with all that being said, we’re able to win tough games and blowouts. All different kinds of wins.”Said Griffin: “To have J.J. hurt for so long and (Paul) and Jamal and Matt Barnes hurt, to have all the guys we’ve had hurt this year, yet to be where we are, it’s great.”The true test comes in the playoffs, of course.But the more the Clippers show they can win when Plan A and Plan B aren’t working, the better off they’ll be in April and May.“Listen, in the playoffs every game’s not going to be pretty,” Collison said. “It’s going to be hard, especially against a very good team.“There’s going to be times you aren’t playing well, but you have to do whatever it takes to win.”The Clippers are doing that now. The source of which dramatically increases the odds of a long playoff run by the Clippers.Despite so many factors working against them, they dug deep enough to forge a path to victory against one of the best teams in the Western Conference — not to mention their recent nemesis.It wasn’t pretty or artistic or imaginative.But in many ways, it was better than all of those things combined.They won ugly, relying more on mental toughness than physical prowess. It didn’t come easy. They had to keep chipping away until the game tilted their way long enough to prevail. Newsroom GuidelinesNews TipsContact UsReport an Error Doc Rivers wasn’t quite done listing everything that didn’t work for the Clippers against the Golden State Warriors on Wednesday, yet already he was running out of breath.“We were awful offensively. We just scored on happenstance. Guys found the ball and made a shot,” Rivers said. “We had no rhythm. We had no pace. We had no execution. And we were fighting ourselves.”It was a bleak assessment, to be sure.But behind the raspy voice detailing the woes, an unmistakable sense of satisfaction grew more and more obvious.